Literature DB >> 1907375

Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters.

T Chajek-Shaul1, T Hayek, A Walsh, J L Breslow.   

Abstract

Transgenic mice carrying the human apolipoprotein (apo) A-I gene (HuAITg mice) were used to examine the effects of overexpression of the human gene on high density lipoprotein (HDL) particle size distribution and metabolism. On a chow diet, control mice had HDL cholesterol and apo A-I levels of 49 +/- 2 and 137 +/- 12 mg/dl of plasma, respectively. HuAITg mice had HDL cholesterol, human apo A-I, and mouse apo A-I levels of 88 +/- 2, 255 +/- 19, and 16 +/- 2 mg/dl, respectively. Nondenaturing gradient gel electrophoresis revealed control mouse plasma HDL to be primarily monodisperse with a particle diameter of 10.2 nm, whereas HuAITg mouse plasma HDL was polydisperse with particles of diameter 11.4, 10.2, and 8.7 nm, which correspond in size to human HDL1, HDL2, and HDL3, respectively. In vivo turnover studies of HDL labeled with [3H]cholesteryl linoleyl ether (representing the cholesteryl ester pool) and 125I-apo A-I were performed. In control animals, the fractional catabolic rate (FCR) for HDL cholesteryl ester (0.197 +/- 0.010 pool/hr) was significantly (P less than 0.0005) more than the apo A-I FCR (0.118 +/- 0.006 pool/hr). In the HuAITg mice, the HDL cholesteryl ester FCR (0.124 +/- 0.008 pool/hr) was the same as the apo A-I FCR (0.126 +/- 0.010 pool/hr). There were no significant differences between control and HuAITg animals in the sites of tissue removal of HDL cholesteryl ester, with the liver extracting most of the injected radioactivity. Control and HuAITg animals had comparable liver and intestinal cholesterol synthesis and LDL FCR. In conclusion, HuAITg mice have principally human and not mouse apo A-I in their plasma. This apparently causes a change in HDL particle size distribution in the transgenic mice to one resembling the human pattern. The replacement of mouse by human apo A-I also apparently causes the loss of the selective uptake pathway of HDL cholesteryl esters present in control mice. These data imply that apo A-I primary structure has a profound influence on HDL particle size distribution and metabolism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1907375      PMCID: PMC52162          DOI: 10.1073/pnas.88.15.6731

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Efficient trace-labelling of proteins with iodine.

Authors:  A S McFARLANE
Journal:  Nature       Date:  1958-07-05       Impact factor: 49.962

Review 2.  Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism.

Authors:  D Reichl; N E Miller
Journal:  Arteriosclerosis       Date:  1989 Nov-Dec

Review 3.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

4.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

Authors:  D W Bilheimer; S Eisenberg; R I Levy
Journal:  Biochim Biophys Acta       Date:  1972-02-21

5.  Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism.

Authors:  M E Whitlock; T L Swenson; R Ramakrishnan; M T Leonard; Y L Marcel; R W Milne; A R Tall
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

6.  Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins.

Authors:  M L Brown; A Inazu; C B Hesler; L B Agellon; C Mann; M E Whitlock; Y L Marcel; R W Milne; J Koizumi; H Mabuchi
Journal:  Nature       Date:  1989-11-23       Impact factor: 49.962

7.  Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.

Authors:  E M Rubin; B Y Ishida; S M Clift; R M Krauss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

8.  Evaluation of pathways for the cellular uptake of high density lipoprotein cholesterol esters in rabbits.

Authors:  D I Goldberg; W F Beltz; R C Pittman
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

9.  High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3.

Authors:  A Walsh; Y Ito; J L Breslow
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

10.  Measurement of normative HDL subfraction cholesterol levels by Gaussian summation analysis of gradient gels.

Authors:  R B Verdery; D F Benham; H L Baldwin; A P Goldberg; A V Nichols
Journal:  J Lipid Res       Date:  1989-07       Impact factor: 5.922

View more
  23 in total

1.  Quantitative trait loci influencing cholesterol and phospholipid phenotypes map to chromosomes that contain genes regulating blood pressure in the spontaneously hypertensive rat.

Authors:  A Bottger; H A van Lith; V Kren; D Krenová; V Bílá; J Vorlícek; V Zídek; A Musilová; M Zdobinská; J M Wang; B F van Zutphen; T W Kurtz; M Pravenec
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.

Authors:  T Hayek; T Chajek-Shaul; A Walsh; L B Agellon; P Moulin; A R Tall; J L Breslow
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  A comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteins.

Authors:  Scott M Gordon; Hailong Li; Xiaoting Zhu; Amy S Shah; L Jason Lu; W Sean Davidson
Journal:  J Proteome Res       Date:  2015-04-27       Impact factor: 4.466

4.  HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function.

Authors:  Stela Z Berisha; Greg Brubaker; Takhar Kasumov; Kimberly T Hung; Patricia M DiBello; Ying Huang; Ling Li; Belinda Willard; Katherine A Pollard; Laura E Nagy; Stanley L Hazen; Jonathan D Smith
Journal:  J Lipid Res       Date:  2015-01-05       Impact factor: 5.922

5.  Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation.

Authors:  Tessa J Barrett; Emilie Distel; Andrew J Murphy; Jiyuan Hu; Michael S Garshick; Yoscar Ogando; Jianhua Liu; Tomas Vaisar; Jay W Heinecke; Jeffrey S Berger; Ira J Goldberg; Edward A Fisher
Journal:  Circulation       Date:  2019-09-30       Impact factor: 29.690

6.  Structural studies of a baboon (Papio sp.) plasma protein inhibitor of cholesteryl ester transferase.

Authors:  G W Buchko; A Rozek; P Kanda; M A Kennedy; R J Cushley
Journal:  Protein Sci       Date:  2000-08       Impact factor: 6.725

Review 7.  Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins.

Authors:  Baiba K Gillard; Corina Rosales; Bingqing Xu; Antonio M Gotto; Henry J Pownall
Journal:  J Clin Lipidol       Date:  2018-04-12       Impact factor: 4.766

8.  Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL.

Authors:  Anny Mulya; Ji-Young Lee; Abraham K Gebre; Elena Y Boudyguina; Soon-Kyu Chung; Thomas L Smith; Perry L Colvin; Xian-Cheng Jiang; John S Parks
Journal:  J Lipid Res       Date:  2008-06-25       Impact factor: 5.922

9.  Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-I transgenic and control mice.

Authors:  T Hayek; Y Ito; N Azrolan; R B Verdery; K Aalto-Setälä; A Walsh; J L Breslow
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.

Authors:  C Pászty; N Maeda; J Verstuyft; E M Rubin
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.